secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xilio Therapeutics, Inc. (XLO)
CIK:        0001840233
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001558370-24-004249
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Xilio Therapeutics issues 6.86M shares to Gilead at $1.97/share for $13.5M private placement
--------------------------------------------------------------------------------

- Closed private placement of 6,860,223 shares to Gilead Sciences at $1.97/share for ~$13.5M.
- Shares issued under an exclusive license agreement previously disclosed.
- Shares outstanding increased from 27,613,263 to 34,473,486.
- Placement closed on March 28, 2024, as part of strategic collaboration with Gilead.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840233/000155837024004249/0001558370-24-004249-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840233/000155837024004249/xlo-20240328x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-004249

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer